Skip to Main Content
Qurgen Qurgen
Menu Button

June-July 2025

Brand Icon
During June-July of 2025, Qurgen had successfully manufactured two batches of GMP-scaled SON-DP drug products which will be used in both of US and China Phase I clinical trials.

Recent important events

Mar. 2026
Qurgen announced that the blood and biopsy tissue testing results of a late-stage of ocular...
Learn More
Jan. 13, 2026
Dr. Chai Yan officially Joined Qurgen/Fuent (Qurgen’s primary China subsidiary) as Senior Vice President of...
Learn More